Potent and selective amylin receptor antagonist that displays 38-fold and 400-fold selectivity over calcitonin and CGRP receptors respectively. Through attenuating the activation of initiator and effector caspases in vitro, it blocks amyloid β-induced neurotoxicity. It can increase glucagon secretion, accelerate gastric emptying, change plasma glucose levels and increase food intake in vivo.
CAT No: R0952
CAS No:151804-77-2
Synonyms/Alias:151804-77-2;AC 187;AC187;salmon calcitonin (8-32) reduced;CID 16133792;GTPL689;AKOS024457619;acetyl-(Asn30,Tyr32)-calcitonin8-32;FA109403;Acetyl-(Asn30,Tyr32)-Calcitonin (8-32) (salmon I) trifluoroacetate salt;161902-50-7;
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.